---
title: "Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes"
nct_id: NCT01726062
overall_status: COMPLETED
phase: PHASE2
sponsor: The University of Texas Health Science Center, Houston
study_type: INTERVENTIONAL
primary_condition: Exposure to Secondhand Smoke in Neonatal Infants
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01726062.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01726062"
ct_last_update_post_date: 2018-05-14
last_seen_at: "2026-05-12T06:14:34.585Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes

**Official Title:** Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes (The Baby's Breath II Project)

**NCT ID:** [NCT01726062](https://clinicaltrials.gov/study/NCT01726062)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE2
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 360
- **Lead Sponsor:** The University of Texas Health Science Center, Houston
- **Collaborators:** Memorial Hermann Hospital, National Heart, Lung, and Blood Institute (NHLBI)
- **Conditions:** Exposure to Secondhand Smoke in Neonatal Infants
- **Start Date:** 2012-08
- **Completion Date:** 2018-01-30
- **CT.gov Last Update:** 2018-05-14

## Brief Summary

A randomized, controlled, parallel group design will be used to test whether a Secondhand Smoke Exposure program initiated in the hospital and completed in the home using motivational interviewing plus motivational incentives (MI+) is more effective than Conventional Care (CC) with Neonatal Incentives Care Unit Infants' parents.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Have an infant that is at least 1 week prior to the estimated date of hospital discharge in the NICU at Children's Memorial Hermann Hospital (CMHH)
* Report at least one person living in the home who smokes
* Agree to attend intervention sessions and to invite other household members
* Live within 50 miles of our center
* Have access to a telephone.

Exclusion Criteria:

* Severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol
* Inability to read, write, and speak English or Spanish
* Inability or unwillingness to provide signed consent for participation
* Inability or unwillingness to meet study requirements, including home visits for data collection and intervention purposes.
```

## Arms

- **Motivational Interviewing plus Incentives** (EXPERIMENTAL)
- **Conventional Care (CC)** (OTHER)

## Interventions

- **Motivational Interviewing plus Incentives** (BEHAVIORAL) — 1. Two hospital-based, face-to-face MI+ sessions
2. Two home-based MI+ sessions
3. Attendance at each session and for the establishment of a household smoking ban at two timepoints post-discharge
- **Conventional Care (CC)** (BEHAVIORAL) — Participants in this arm will receive brochures and a brief information meeting in the NICU.

## Primary Outcomes

- **Infant Second-Hand Smoke Exposure via Urine Cotinine** _(time frame: Follow-up visit 4 months post-treatment)_ — Infant Second-Hand Smoke Exposure (SHSe) measures will be determined via urine cotinine.

## Secondary Outcomes

- **Secondhand Smoke Exposure outcomes** _(time frame: Change from Baseline to the 4 months post-treatment followup)_

## Locations (1)

- Children's Memorial Hermann Hospital, Houston, Texas, United States

## Recent Field Changes (last 30 days)

- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.children's memorial hermann hospital|houston|texas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01726062.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01726062*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*